- Home
- / Cogentix Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Cogentix Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$4.9
2022-08-04
Market Capitalization
$327.3 M
2022-08-04
Revenue
$56.3 M
FY, 2017
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2012 | FY, 2013 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|---|
| Revenue | 16.7M | 15.3M | 26.5M | 51.9M | 56.3M |
| Revenue growth, % | 95.5% | 8.6% | |||
| Cost of goods sold | 11.6M | 10.9M | 3.1M | 16.2M | 18.9M |
| Gross profit | 5.1M | 4.3M | 23.4M | 35.6M | 37.4M |
| Gross profit margin, % | 30.5% | 28.4% | 88.2% | 68.7% | 66.5% |
| General and administrative expense | 12.0M | 11.0M | 8.0M | 6.8M | 8.3M |
| Operating expense total | 15.2M | 12.8M | 31.0M | 37.4M | 38.3M |
| Depreciation and amortization | 2.4M | 2.4M | |||
| EBIT | (10.1M) | (8.5M) | (7.6M) | (1.8M) | (889.5K) |
| EBIT margin, % | -60.6% | -55.5% | -28.8% | -3.5% | -1.6% |
| Investment income | (686.0K) | ||||
| Interest income | 9.0K | 4.0K | 8.5K | 25.5K | 245.7K |
| Interest expense | 489.0K | 503.0K | 489.0 | 1.3M | 29.0K |
| Pre tax profit | (11.0M) | (10.5M) | (7.6M) | (22.0M) | (617.0K) |
| Income tax expense | 1.0K | 12.0K | 65.5K | 144.8K | 137.1K |
| Net Income | (11.0M) | (10.6M) | (7.7M) | (22.1M) | (882.7K) |